Rentschler Biotechnologie extends capacities for mammalian cell culture manufacturing
24-Jun-2008 -
Rentschler Biotechnologie started operation of a 2,500 L multi-process production suite. Hence, Rentschler Biotechnologie now has nine stand-alone GMP suites with volumes of 30, 250, 500 and 2,500 liters, allowing the production of material for clinical trials and for market supply.
The modern, ...
Boehringer Ingelheim
cell cultures
clinical trials
+1